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Background: Social cognitive variables are often examined for their association with initial participation in
colorectal cancer screening. Few studies have examined the association of these variables with adherence to
multiple screening offers i.e., rescreening. This study aimed to describe patterns of participatory behaviour after
three rounds of screening using faecal immunochemical tests (FIT) and to determine social cognitive, demographic
and background variables predictive of variations in adherence.
Methods: Participants were 1,540 men and women aged 50 to 75 living in South Australia who completed a
behavioural survey measuring demographic (for example, age, gender) and social cognitive variables relevant to FIT
screening (for example, perceived barriers, benefits, self-efficacy). The survey was followed by three, free FIT
screening offers mailed on an annual basis from 2008 to 2010. Patterns of participation after three screening rounds
were described as one of five screening behaviours; 1) consistent re-participation (adherent with all screening
rounds), 2) consistent refusal (adherent with no screening rounds), 3) drop out (adherent with earlier but not later
rounds), 4) intermittent re-participation (adherent with alternate rounds) and 5) delayed entry (adherent with later
but not initial round(s)). Univariate (Chi Square and Analysis of Variance) and multivariate (Generalised Estimating
Equations) analyses were conducted to determine variables predictive of each category of non-adherence (those
that did not participate in every screening offer, groups 2, 3, 4 and 5) relative to consistent re-participation.
Results: Significant social cognitive predictors of non-adherence were; less self-efficacy (drop out and consistent
refusal), greater perceived barriers (drop out) and lower levels of response efficacy (consistent refusal). Demographic
predictors of non-adherence included; male gender (delayed entry), younger age (intermittent, delayed and
consistent refusal), less frequent GP visits (intermittent re-participation) and 'ancillary only' private health insurance
(drop out). Less satisfaction with screening at baseline predicted drop out, consistent refusal and delayed entry.
Conclusions: Different combinations of demographic and behavioural variables predicted different patterns of
rescreening adherence. Rescreening interventions may benefit from a targeted approach that considers the
different needs of the population subgroups. Satisfaction with past FOBT screening measured prior to the study
screening offers was an important predictor of adherence.
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Adherence to recommendations for screening with faecal
occult blood tests (FOBT) has been shown to reduce inci-
dence of, and mortality from, colorectal cancer (CRC) [1].
In Australia, screening using faecal immunochemical tests
for haemoglobin (FIT, a type of FOBT) is recommended at
least once every two years for those aged 50 and over [2,3].
Screening programs utilising FOB-based tests have been
established in many countries including The Netherlands,
Italy, the United Kingdom, Australia and France [4,5]. Ini-
tial uptake and continued adherence to screening recom-
mendations are crucial to the success of these programs
[3,6]. Recent research has highlighted the importance of
using longitudinal observations of screening participation
to measure adherence adequately [7-11]. Studies of this na-
ture have documented low rates of ongoing adherence ran-
ging from 13.7% [7] to 39.2% [11] for recommended levels
of screening participation (i.e., participation in all screening
offers) over more than two screening rounds. These find-
ings highlight the importance of moving beyond identifica-
tion of the factors that predict initial uptake to those
associated with screening relapse (i.e., program dropout)
and other irregular patterns of participation.
The majority of past CRC screening research has fo-
cused on predictors of participation in single screening
opportunities (i.e., initial uptake or other one-off oppor-
tunities) [12-14]. These studies have established the util-
ity of including social cognitive measures to explain
initial screening participation and form the basis of
many behavioural interventions to improve adherence
[12-14]. Our previous work has extended this in order to
explore the relationship between social cognitive vari-
ables and intention to rescreen. Significant predictors of
rescreening intention included satisfaction with prior
FOBT screening, awareness of the need to repeat screen-
ing, greater self-efficacy, greater perceived benefits of
screening and fewer perceived barriers [15]. The focus of
the current study was to determine predictors of con-
secutive participation in more than one screening oppor-
tunity (i.e., repeat or continued adherence) which, from
here on, will be referred to as rescreening. Existing re-
search on rescreening has, to date, been primarily lim-
ited to an examination of demographic and background
(i.e., health systems) factors [9,10,16-19]. Significant
positive predictors include greater frequency of general
practitioner (GP) visits [17,19], older age [17,18] and
male gender [9,17]. However, no studies have examined
the utility of social cognitive variables for predicting on-
going adherence.
Recent research has highlighted the importance of
utilising descriptive frameworks that encompass multiple
participatory patterns of behaviour when measuring, and
predicting, rescreening adherence [9,11,18,20]. These
frameworks not only allow for the exploration of variablespredictive of different non-adherent behaviours (for ex-
ample, drop out behaviour, consistent non-participation)
[9,11,18,20] but they also provide a more accurate measure
of ongoing adherence compared to cross sectional data [7].
There is evidence to suggest that interventions targeted to
population subgroups are more successful in encouraging
participation than a standard population approach [21,22].
Identifying the needs of different non-adherent subgroups
could therefore inform the development of interventions to
target demographic or behavioural factors that predict vari-
ous patterns of non-adherent behaviour [9].
The primary aim of this study was to identify factors
significantly associated with different categories of ad-
herence defined according to patterns of participation
observed after three annual FIT screening offers. Poten-
tial social cognitive, demographic and background fac-
tors measured at baseline, prior to the first screening
offer, and derived from behavioural models that have
successfully predicted initial screening uptake [12] were
tested for their ability to predict variations in rescreening
adherence. The study also aimed to explore the add-
itional contribution of satisfaction with screening, mea-
sured prior to the study screening offers, on adherence
to patterns of rescreening in the study.
Methods
Study population
The study population were 4000 men and women aged
50–75, residing in the surrounding suburbs of Adelaide,
South Australia, who were selected at random from data
provided by the Australian electoral roll. Elector details
were cross checked against a CRC high risk database at
the Bowel Health Service (BHS) Repatriation General
Hospital in South Australia. Those known to be at high
risk for CRC (as identified in the database), defined as
having a personal or family history of CRC, or long
standing irritable bowel conditions [23], were excluded
from possible selection.
Study design
This study consisted of two phases; the survey phase
(baseline) and the screening phase (following baseline).
All social cognitive, demographic and background vari-
ables utilised in this study were measured in the baseline
behavioural survey and used to predict participation in
three subsequent screening offers (prospective design).
Participants were mailed a baseline behavioural survey
in November of 2008 (survey phase). Those who com-
pleted the survey were then invited to participate in free
FIT screening coordinated by the BHS on an annual
basis for a period of three years (screening phase). In the
first instance, survey respondents were mailed the FIT
two weeks following return of the survey. Subsequent
screening offers were mailed from October 2009 and
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the initial offer. Offers were not mailed when 1) an in-
vitee contacted the BHS to opt out of the study or 2) a
positive test result in a preceding round, with follow up
diagnostic evaluation, precluded the need for further of-
fers. Participants provided informed consent to partici-
pate in the study via return of the completed survey and
for each screening offer via return of a participant details
and consent form and/or return of the completed FIT.
Materials
Behavioural survey
The survey, administered before the first screening offer
(baseline), was designed to collect information on a var-
iety of social cognitive, demographic and other back-
ground variables likely to predict rescreening. This
survey has also been described in detail in a paper that
reports associations with rescreening intention [15].
Demographic variables Demographic variables in-
cluded age, gender, education, employment, level of pri-
vate health insurance coverage and index of relative
socioeconomic disadvantage defined according to post-
code [24].
Social cognitive variables Social cognitive measures
were; barriers and benefits of FOBT screening, perceived
CRC susceptibility and severity, level of social influence
(from family, friends and health professionals) to screen,
a general measure of perceived social support, self-
efficacy for completing screening, confidence in FOBT
effectiveness (response efficacy), chance health locus of
control (belief that health is controlled by chance), in-
ternal health locus of control and health value. Social
cognitive items (excluding response efficacy whichTable 1 Social cognitive items included in the behavioural qu
Variable Example
Chance health locus
of control
“My good health is largely a matter of good fortune”
Internal health locus
of control
“If I take the right actions I can stay healthy”
Health value “If you don’t have your health you don’t have anythin
Response efficacy “Participation in home stool test screening leads to ea
Self-efficacy “I am confident that I will be able to screen regularly
even if I find the test to be embarrassing”
Barriers “Home stool tests are inconvenient”
Benefits “Screening can pick up bowel cancer early when it ca
Severity “The health consequences of developing bowel canc
Susceptibility “Compared to other people my age my chance of ge
Social support “I can count on my friends when things go wrong”
Social influence “My doctor thinks I should have bowel cancer screenutilised a three point scale with response options of no,
unsure and yes) were measured using 5 point Likert
scales ranging from strongly disagree to strongly agree.
Existing scales were used where possible and example
items are provided in Table 1. The measures of per-
ceived barriers and benefits included items from a previ-
ous questionnaire designed to measure beliefs regarding
initial screening uptake [25] along with new items de-
signed to assess barriers and benefits of rescreening (for
example, “having regular home stool tests would give me
peace of mind about my health”). A new measure of
self-efficacy was also developed for this questionnaire
based on the measurement recommendations of Luszc-
zynska and Schwarzer [26].
Background variables Participants’ knowledge of CRC
risk factors (age, family history and lifestyle/diet) and
CRC screening (the importance of early detection and
treatment, the need to rescreen) were measured using 6
items (example; ‘it is not necessary to screen again for
bowel cancer if your previous screening test was nor-
mal’) with response options yes, no and don’t know/un-
sure. Three yes/no items measured participants’ social
interactions concerning CRC (known anyone who has
had bowel cancer) and screening (discussed home stool
testing with anyone, known anyone who has used a
home stool test). Other background items included; fre-
quency of general practitioner visits in the year preced-
ing the study (ranging from none to five or more visits)
and engagement in other types of cancer screening be-
haviour (yes or no). Family history of CRC and prior
cancer diagnoses (other than CRC) were also measured.
Participants were asked if they had used an FOBT to
screen for bowel cancer prior to their involvement in the
present study (self-report past FOBT use). Those whoestionnaire
Items Source
4 Wallston et al. [27]
2 Wallston et al. [27]
g” 4 Lau & Hartman
[28]
rly detection if something is wrong.” 4 Boer & Seydel [29]
for bowel cancer with a home stool test 6 -
7 -
n be easily treated” 4 -
er are severe” 2 Gregory et al. [25]
tting bowel cancer is high” 2 Gregory et al. [25]
6 Gregory et al. [25]
ing” 4 Tiro et al. [30]
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asked to indicate their overall satisfaction with their past
screening experience on a 5 point Likert scale ranging
from very unsatisfied to very satisfied.
FIT screening offer
Annual screening offers were mailed from the BHS and in-
cluded; 1) an invitation letter, 2) a two sample immuno-
chemical FIT kit (OC-Sensor, Eiken Chemical Co., Tokyo,
Japan), 3) a bowel cancer information brochure, 4) a com-
bined participant details and consent form, 5) a reply-paid
envelope and 6) a screening status information form where
participants could provide details of participation in other
CRC screening tests outside of the study. Reminder letters
were mailed to non-participants after six weeks.
Study outcomes
Screening adherence, determined after three annual FIT
screening rounds, was the primary outcome of the study.
Adherence per round was measured based on either return
of the completed study FIT or self-reported adherence with
other CRC screening (for example, colonoscopy or FOBT
obtained elsewhere) within the yearly observation period
for each offer. Self-report was obtained either via the
screening status information form or by participants con-
tacting the BHS directly. Those reporting use of endoscopic
screening, (colonoscopy or flexible sigmoidoscopy), with or
without study FIT utilisation, were excluded from analyses.
This exclusion was because the focus of this study was to
determine the relevance of questionnaire variables to the
prediction of rescreening adherence using FOB-based
screening tests.
Participants were coded as adherent (Y) or non-
adherent (N) for each round resulting in eight possible
patterns of participation. Participants were first coded
according to participation in the study FIT. Additional
self-report data for participation in other FOBTs were
then included. This process ensured that observed FIT
participation was the main source of data, which was
then supplemented with self-report data.
Defining patterns of participatory behaviour
The eight possible patterns of participation were col-
lapsed into five categories of adherence behaviour based
on those described by Cole et al. [9]. The categories
were; consistent re-participation (adherent with all
screening rounds; target behaviour), consistent refusal
(adherent with no screening rounds), drop out (partici-
pation round one and/or round two followed by subse-
quent refusal) and delayed entry (initial refusal followed
by participation in later rounds). An additional behav-
ioural category, intermittent re-participation, was also
included in order to describe those who dropped out in
round two but then re-participated in the final screeninground. The eight participation patterns and associated
adherence categories are described in Table 2.
Analyses
Primary analyses Univariate (ANOVA and Chi squared)
comparisons with post hoc tests (Hochberg GT2 and Chi
Square with a Bonferroni correction) were conducted com-
paring consistent re-participation with each remaining cat-
egory (the ‘non-adherent’ categories; drop out, intermittent
re-participation, delayed entry, consistent refusal) for each
of the demographic, background and social cognitive
variables. Skewed variables were analysed using non-
parametric alternatives [31]. Significant differences deter-
mined at the univariate level were then incorporated into
four separate multivariate models, utilising log Poisson
Generalised Estimating Equations (GEE), with consistent
re-participation as the referent category.
Secondary analyses To determine the impact of satis-
faction with screening before study involvement on ad-
herence to screening offered during the study, a second
multivariate analysis was conducted on the subpopula-
tion of participants who indicated in the baseline survey
that they had used an FOBT in the past (self-reported
past FOBT use). These models incorporated all the vari-
ables included in the primary multivariate analyses with
the addition of a single item measure of satisfaction with
past screening.
Exclusions
Questionnaire response rate was 48.5% (1941/4000).
Thirteen respondents requested no further contact fol-
lowing questionnaire completion therefore annual
screening was offered to the remaining 1928 respon-
dents. Screening invitees who participated in endoscopic
screening (colonoscopy/FS; n = 240, 12.4%) and those
with incomplete questionnaire data (n = 148, 7.6%) were
excluded from analyses. The remaining 1,540 question-
naire respondents (79.3%) were included in the analyses
for this study as outlined in Figure 1.
Ethical considerations
This study has been approved by the Human Research
Ethics Committees at the University of Adelaide and the
Repatriation General Hospital.
Results
Description of the sample
The final sample (n = 1540) comprised 710 (46.1%) men
and 830 (53.9%) women aged 50–75 (mean = 59.94, SD =
6.48). Of the study sample 1,412 (91.75%) participated
only in the FIT offered by the BHS whilst the remaining
128 (8.25%) reported other FOBT participation either in
Table 2 FIT screening patterns and behaviours defined after three annual screening rounds
Participation patterns across three screening rounds Adherence category
Round 1 Round 2 Round 3
Y Y Y Consistent re-participation
Y Y N
Drop outY N N
N Y N
Y N Y Intermittent re-participation
N Y Y
Delayed entry
N N Y
N N N Consistent refusal
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BHS. The majority were married (n = 1189, 77.2%), had
completed at least secondary school education (n = 1041,
67.6%), spoke English at home (n = 1329, 86.3%), were
born in Australia (n = 1094, 71.0%), and just over half
were still in the workforce (n = 802, 52.1%). Index of rela-
tive disadvantage scores were divided into quintiles with
the lowest quintile (1) indicating greater levels of disad-
vantage and the highest (5) indicating lower levels of dis-
advantage. A substantial portion of participants were in
the highest (n =453, 29.4%) and lowest quintiles (n = 326,
21.2%) with the remainder spread approximately evenly be-
tween. These scores indicate that participants were from a
broad range of socioeconomic backgrounds with slightly
larger clusters at each extreme. Compared to survey non
respondents, survey respondents were more likely to be
from less disadvantaged areas (χ2 (4) = 68.36, p < .001) and
were slightly less likely to be from the youngest (50–54,Figure 1 Process of determining eligibility for analyses.55–59) and oldest (70–74) age groups (χ2 (5) = 24.92,
p < .001).Rescreening adherence
Table 3 shows the proportion of participants for each
category of adherence. Just over 55% of invitees were ad-
herent with annual screening after three years.Univariate differences between consistent re-participation
and non-adherence
Table 4 shows the significant univariate predictors of
categories of non-adherence compared to consistent re-
participation. Significant post hoc comparisons, indi-
cated with asterisks, highlight differences between con-
sistent re-participation and each of the non-adherent
categories. Social cognitive variables only differentiated
consistent re-participation from drop out and consistent
Table 3 Proportion of study participants in each
adherence category upon study completion
(i.e., at year 3)
Adherence category Number (%)
Consistent re-participation 860 (55.8%)
Drop out 134 (8.7%)
Intermittent re-participation 68 (4.4%)
Delayed entry 166 (10.8%)
Consistent refusal 312 (20.3%)
Total 1540 (100%)
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behavioural categories as shown in Table 5.
Multivariate predictors of non-adherence (primary
analyses)
Table 6 presents the results of four separate multivariate
models with consistent re-participation as the referent
category for each. Risk ratios (RR) above 1 indicate an
increase in the likelihood of being in the comparative
non-adherent category compared with consistent re-
participation, and a value below 1 indicates a decrease in
likelihood. All social cognitive variables were measured
on an increasing scale. Only variables that were identi-
fied post hoc as being associated with each category
were entered into the multivariate models, therefore
each model varies in terms of potential predictors. Sig-
nificant multivariate predictors are highlighted in bold.
Three social cognitive variables significantly predicted
variations in adherence; a perception of more extensive bar-
riers and lower confidence in utilising the FIT (i.e., less self-
efficacy) predicted drop out behaviour. Lower confidence in
both personal capacity (i.e., self-efficacy) and test effective-
ness (i.e., response efficacy) significantly predicted consist-
ent refusal although the risk ratios were small.
Several demographic and background variables predicted
non-adherence to rescreening. Significant predictors of
drop out were; having 'ancillary' only private health insur-
ance cover and no past FOBT use a. Younger age and fewer
GP visits in the year preceding the study predicted intermit-
tent re-participation, whilst those who entered the screen-
ing program later (delayed entry) were more likely to be
male and younger, and less likely to have known someone
who has screened with a FOBT. Those who consistently re-
fused the screening offers were less likely to be from areas
of moderate disadvantage, were younger, had not used a
FOBT in the past and were less likely to have known some-
one else who had used a FOBT.
Satisfaction with past FOBT use (secondary analyses)
A measure of satisfaction was only available for partici-
pants who reported in the baseline questionnaire that
they had participated in FOBT screening before beinginvited into the present study (self-reported past FOBT
use, n = 720). Among this subsample there were substan-
tially more participants in the consistent re-participation
category (n = 482, 66.9%) and substantially less in the
consistent refusal category (n =78, 10.8%) when com-
pared to the full sample. Proportions of those in the de-
layed entry (n = 83, 11.5%), intermittent re-participation
(n = 32, 4.4%), and drop out (n = 45, 6.3%) categories
remained relatively similar in the subpopulation.
Details of past screening were limited to a single item
measure of overall satisfaction with the screening experi-
ence. To determine the potential impact of satisfaction
with past screening on non-adherence to the screening
offered in this study the multivariate models described
previously (primary analyses) were repeated for the re-
duced sample with the addition of the satisfaction meas-
ure as shown in Table 7. Contrary to the primary
analyses, social cognitive variables did not differentiate
categories of non-adherence amongst a sample of partic-
ipants who had previously participated in FOBT screen-
ing when satisfaction with past screening was taken into
account. However, less satisfaction with past screening,
was significantly predictive of all non-adherent behav-
iours with the exception of intermittent re-participation.
Discussion
Recent studies have highlighted the importance of moni-
toring longitudinal screening adherence in order to
measure rescreening accurately [7,9,11]. In this study,
ongoing adherence was measured according to a prede-
fined framework that described a variety of screening be-
haviour patterns over a period of three years [9]. Results
show just over 55% of participants provided with annual
invitations to screen with FIT were adherent with all
three rounds. A substantial portion of participants were
non-responsive to all invitations (20.3%), and irregular
patterns of adherence were observed for the remaining
24%.
The substantial portion of those who participated at ir-
regular intervals, or refused screening altogether, over a
three year time frame highlight the importance of identi-
fying ways to encourage ongoing adherence in order to
maximise the population benefit of FOB-based screening
programs [3,11]. Furthermore, results found different
demographic and behavioural variables to be predictive
of different patterns of adherence over the three year ob-
servation period. These findings support the hypothesis
that different types of non-adherent behaviours are likely
to respond to different types of interventions [9].
Identifying demographic sub groups less likely to respond
to ongoing screening opportunities can assist with the de-
sign of targeted interventions to improve adherence [9].
Some demographic predictors of rescreening (for example,
older age [17]) have already been identified. This study is
Table 4 Significant social cognitive differences between consistent re-participation and each non-adherent category
Variable Consistent
re-participation (n = 860)
Drop out
(n = 134)
Intermittent re-participation (n = 68) Delayed entry
(n = 166)
Consistent refusal
(n = 312)
F(df) p
Mean (SD)
Barriers 16.28 (4.22) 17.96 (4.33)** 16.51 (3.65) 16.57 (4.34) 18.04(4.80)** 12.46 (4,709.51) <.001
Benefits 16.14 (1.96) 15.74 (1.99) 15.96 (1.75) 15.90 (1.93) 15.07(2.24)** 16.49 (4,1535) <.001
Self-efficacy 23.73 (4.69) 22.36 (4.29)* 23.63 (4.22) 23.35 (4.61) 21.57(5.01)** 14.24 (4,678.72) <.001
Response efficacy 11.06 (1.45) 11.26 (1.13) 10.79 (1.88) 10.96 (1.61) 10.46(1.73)** 36.94 (4)a <.001
Social support 22.96 (3.81) 22.91 (3.61) 22.88 (3.26) 22.47 (3.52) 21.80(4.38)** 5.80 (4,725.81) <.001
Social influence 13.76 (2.60) 13.52 (2.61) 13.13 (2.65) 13.38 (2.43) 12.75(2.78)** 8.79 (4,1535) <.001
Note. F = F ratio; df = degrees of freedom, SD = standard deviation, p = probability. Data were measured on increasing, continuous scales.
adata were not normally distributed therefore the Kruskal-Wallis test was reported.
*p < .05. **p < .01.
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Table 5 Demographic and background differences between consistent re-participation and categories of non-adherence
Variable Consistent
re-participation (n = 860)
Drop out
(n = 134)
Intermittent
re-participation (n = 68)
Delayed entry (n = 166) Consistent refusal (n = 312) F (df) p
Mean(SD)
Agea 61.18 (6.33) 58.86 (6.55)** 57.69 (6.20)** 57.86 (5.57)** 58.57 (6.62)** 19.92 (4,599.32) <.001
GP visitsa 3.98 (1.16) 4.04 (1.13) 3.47 (1.31)** 3.95 (1.23) 3.85 (1.29) 3.29 (4,546.14) .011
Number (%) χ2 (df) p
Private health insurance, None 145 (17.0) 33 (25.0)** 17 (25.0) 31 (18.7) 75 (24.1) 26.80 (12) .008
Ancillary 74 (8.7) 21 (15.9) 6 (8.8) 9 (5.4) 21 (6.8)
Hospital 55 (6.4) 5 (3.8) 4 (5.9) 9 (5.4) 14 (4.5)
Both 579 (67.9) 73 (55.3) 41 (60.3) 117 (70.5) 201 (64.6)
Gender (male) 369 (42.9) 58 (43.3) 24 (35.3) 100 (60.2)** 159 (51.0) 23.48 (4) <.001
Married (yes)b 689 (80.7) 93 (70.5) ** 54 (79.4) 131 (79.4) 222 (71.2)** 16.46 (4) .002
Workforce (yes)b 383 (45.4) 78 (60.0)** 43 (64.2)** 109 (66.5)** 189 (61.4)** 45.88 (4) <.001
Disadvantage, 1 167 (19.4) 28 (20.9) 16 (23.9) 34 (19.4) 81 (26.0)** 36.73 (16) .002
2 140 (16.3) 35 (26.1) 11 (16.4) 26 (15.8) 56 (18.0)
3 152 (17.7) 20 (14.9) 16 (23.9) 20 (12.1) 39 (12.5)
4 149 (17.3) 24 (17.9) 4 (6.0) 31 (18.8) 34 (10.9)
5 (least) 251 (29.2) 27 (20.1) 20 (29.9) 54 (32.7) 101 (32.5)
Knowledge (incorrect)c 124 (14.5) 23 (17.2) 13 (19.4) 23 (13.9) 72 (23.1)** 13.51 (4) .009
Known CRC (yes)b 622 (72.7) 83 (62.9) 43 (63.2) 105 (63.6) 191 (62.0)** 17.40 (4) .002
Discussed FOBT (yes)b 542 (63.0) 65 (48.9)** 39 (57.4) 91 (55.2) 120 (38.7)** 57.59 (4) <.001
Known a screener (yes)b 469 (54.7) 54 (40.6)** 33 (48.5) 63 (38.2)** 93 (30.1)** 63.00 (4) <.001
Past other screening (yes)b 564 (65.9) 80 (60.2) 39 (57.4) 116 (70.3) 174 (56.1)** 14.42 (4) .006
SR past FOBT (yes)b 482 (56.0) 45 (33.6)** 32 (47.1) 83 (50.0) 78 (25.0)** 99.19 (4) <.001
Note. SD = standard deviation; F = F ratio; χ2 = chi square; p = probability; SES = socioeconomic status determined by SEIFA index of disadvantage; knowledge = response to knowledge item regarding the importance of
repeated screening; Known CRC = known a person who has had CRC; Discussed FOBT = ever discussed FOBT screening; Known a screener = known a person who has screened for CRC; Other screening = ever participated in
other (not CRC) screening tests. SR past FOBT = self-reported past FOBT use .avariables were measured on increasing, continuous scales; b comparative category is ‘no’; c comparative category is ‘correct’ *p < .05, ** p < .01.
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Table 6 Multivariate predictors of non-adherence relative to consistent re-participation
Variable Drop out n = 129a Intermittent
re-participation n = 67a
Delayed entry
n = 163a
Consistent refusal
n = 300a
RR p 95% CI RR p 95% CI RR p 95% CI RR p 95% CI
Social cognitive Barriers 1.05 .032 (1.00-1.10) 1.01 .620 (0.98-1.03)
Benefits 0.97 .231 (0.91-1.02)
Self-efficacy 0.97 .047 (0.94-1.00) 0.97 .004 (0.95-0.99)
Response efficacy 0.93 .004 (0.88-0.98)
Social support 1.01 .452 (0.99-1.04)
Social influence 0.97 .281 (0.93-1.02)
Background Known CRC (yes)b 0.88 .173 (0.73-1.06)
Discussed FOBT (yes)b 1.02 .917 (0.71-1.47) 0.97 .806 (0.77-1.23)
Known a screener (yes)b 0.86 .390 (0.60-1.22) 0.72 .029 (0.53-0.97) 0.73 .010 (0.58-0.93)
GP visits 0.80 .015 (0.67-0.96)
Knowledge (incorrect)c 1.07 .573 (0.85-1.33)
Other screening (yes)b 0.88 .168 (0.73-1.06)
SR past FOBT (yes)b 0.66 .042 0.44-0.98 0.59 <.001 (0.45-0.77)
Demographic Age 0.98 .157 (0.94-1.01) 0.93 .007 (0.88-0.98) 0.94 <.001 (0.91-0.97) 0.98 .011 (0.96-0.99)
Workforce (yes)b 1.38 .116 (0.93-2.05) 1.05 .869 (0.60-1.82) 1.21 .302 (0.84-1.75) 1.25 .064 (0.99-1.57)
Married (yes)b 0.77 .133 (0.54-1.09) 0.82 .068 (0.67-1.02)
Private insurance (none)d 1.43 .076 (0.96-2.13)
Private insurance
(ancillary only)d
1.57 .044 (1.01-2.43)
Private insurance
(hospital only)d
0.75 .501 (0.33-1.73)
Gender (male)e 1.77 <.001 (1.32-2.38)
Disadvantage (1) 0.99 .926 (0.78-1.25)
Disadvantage (2) 0.87 .312 (0.66-1.14)
Disadvantage (3) 0.71 .031 (0.53-0.97)
Disadvantage (4)f 0.76 .098 (0.55-1.05)
Note. RR = risk ratio; p = probability; significance level is p<.05, significant values in bold; 95% CI = confidence interval. Social cognitive variables, GP visits and age
were measured on increasing, continuous scales.
knowledge = response to knowledge item regarding the importance of repeated screening; Known CRC = known a person who has had CRC; Discussed FOBT = ever
discussed FOBT screening; Known a screener = known a person who has screened for CRC; Other screening = ever participated in other (not CRC) screening tests; SR past
FOBT = self-reported past FOBT useaCases with missing data were removed list wise, group totals reported in the table report the number of participants included in
each analysis. bReference category is ‘no’ creference category is ‘correct’ dreference category is ‘hospital and ancillary combined cover’; eReference category is ‘female’;
fReference category is the fifth quintile of disadvantage (least disadvantage).
Duncan et al. BMC Public Health 2014, 14:238 Page 9 of 13
http://www.biomedcentral.com/1471-2458/14/238the first to examine predictors of adherence after more than
two screening rounds, and included a broad range of demo-
graphic variables, which led to some new findings. For ex-
ample, results showed that men were more likely to delay
participation in the screening program. Prior research has
consistently reported lower levels of initial FOBT participa-
tion amongst men [32-34]. However these findings suggest
that men may simply take longer to respond to invitations
to screen, and may benefit from different recruitment strat-
egies than women to encourage first time compliance.
Similarly, having private health insurance for ancillary ser-
vices only was predictive of screening drop out but not
associated with other behaviours including consistent non-
participation. Results may reflect concerns about ongoingcosts resulting from follow up testing in initial screening
rounds [35]. Screening programs may want to consider
finding means of providing free follow up examinations to
encourage rescreening.
Consistent with our previous research on rescreening
intention [15], satisfaction with past FOBT screening
was a strong behavioural predictor of adherence to the
study FIT offers. Satisfaction was one of the few vari-
ables to predict multiple screening behaviours with less
satisfaction with past screening predicting likelihood of
drop out, consistent refusal and delayed entry behaviour
by 40%, 26% and 22% respectively. The mammography
screening literature has consistently shown less satisfac-
tion with initial screening to be predictive of non-
Table 7 Multivariate predictors of non-adherence relative to consistent re-participation including a measure of prior satisfaction with FOBT
Variable Drop out n = 40a Intermittent re-participation n = 31a Delayed entry n = 81a Consistent refusal n = 76a
RR p 95% CI RR p 95% CI RR p 95% CI RR p 95% CI
Behavioural (social cognitive
and satisfaction)
Barriers 1.07 .112 (0.98-1.17) 1.00 .873 (0.93-1.06)
Benefits 1.01 .936 (0.89-1.14)
Self-efficacy 1.00 .965 (0.94-1.17) 1.00 .847 (0.96-1.05)
Response efficacy 0.94 .333 (0.82-1.07)
Social support 1.02 .455 (0.97-1.08)
Social influence 0.94 .186 (0.86-1.03)
Satisfaction 0.60 <.001 (0.46-0.78) 0.99 .960 (0.66-1.48) 0.78 .008 (0.65-0.94) 0.74 .005 (0.60-0.92)
Background Known CRC (yes)b 0.80 .348 (0.51-1.27)
Discussed FOBT (yes) b 0.84 .642 (0.40-1.75) 0.82 .465 (0.50-1.37)
Known screener (yes) b 1.20 .582 (0.62-2.31) 0.76 .183 (0.51-1.14) 0.74 .153 (0.49-1.11)
GP visits 0.64 <.001 (0.51-0.82)
knowledge (incorrect)c 1.27 .458 (0.67-2.40)
Other screening (yes) b 0.97 .891 (0.63-1.50)
Demographic Age 0.99 .654 (0.93-1.05) 0.96 .218 (0.89-1.03) 0.93 <.001 (0.89-0.97) 0.97 .209 (0.93-1.02)
Workforce (yes)b 1.92 .067 (0.95-3.84) 1.49 .256 (0.75-3.00) 1.41 .198 (0.84-2.39) 1.73 .054 (0.99-3.03)
Married (yes)b 0.95 .896 (0.45-1.95) 0.98 .918 (0.61-1.57)
Gender (male)d 2.00 .002 (1.30-3.10)
Disadvantage (1) 0.49 .050 (0.24-1.00)
Disadvantage (2) 0.66 .155 (0.37-1.17)
Disadvantage (3) 0.41 .023 (0.19-0.88)
Disadvantage (4)e 0.48 .032 (0.25-0.94)
Note. RR= risk ratio; p= probability, 95% CI= confidence interval.Social cognitive variables, satisfaction, GP visits and age were measured on increasing, continuous scales. Health insurance was not included as a
predictor in secondary analyses as cell sizes were <5 for drop out participants with only ancillary and only hospital cover.
knowledge= response to knowledge item regarding the importance of repeated screening; Known CRC= known a person who has had CRC; Discussed FOBT= ever discussed FOBT screening; Known a screener=
known a person who has screened for CRC; Other screening= ever participated in other (not CRC) screening tests. a Cases with missing data were removed list wise, group totals reported in the table report the
number of participants included in each analysis. b Reference category is ‘no’ c reference category is ‘correct’; d Reference category is ‘female’; e Reference category is the fifth quintile of disadvantage (least
disadvantage).
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http://www.biomedcentral.com/1471-2458/14/238adherence to a subsequent offer [36,37]. Results of the
present study indicate that satisfaction can also have an
ongoing effect on adherence leading to consistent refusal
of multiple screening offers as well as irregular participa-
tory patterns. The importance of ensuring initial and
continued satisfaction with screening cannot be underes-
timated. Future rescreening research should consider ex-
ploring which aspects of screening, for example, the type
of FOB test utilised [38], the service provided as part of
the screening experience [37] or the receipt of abnormal
test results [16] may contribute to perceived satisfaction
and how these factors may be improved to encourage
rescreening.
A review of the screening literature where faecal occult
blood tests have been used indicates that social cognitive
variables can predict initial screening uptake [12] and
rescreening intention [15]. In the present study, greater
perceived barriers and less self-efficacy predicted drop
out behaviour whilst less self-efficacy and less confidence
in the efficacy of the test (response efficacy) predicted
consistent non-participation. Social cognitive variables
did not predict either delayed entry or inconsistent re-
participation. Results indicate that interventions target-
ing relevant beliefs, for example those that aim to reduce
perceived barriers to screening, emphasise the utility of
FOBT for early detection (e.g., improve perceived effect-
iveness and utility of the screening test), and highlight
ease and simplicity of testing (e.g., improve confidence
in personal ability to complete the test), may improve
rescreening adherence for subgroups of the population.
The relationship between greater perceived barriers,
lower self-efficacy and non-adherence to initial screening
has been well established [12,13]. The finding that con-
sistent refusal of screening in this study was associated
with lower response efficacy for FOBT screening is an in-
teresting contribution. Whilst several qualitative studies
have highlighted participant concerns about the efficacy
of home stool tests [35,39] few quantitative investiga-
tions have established a relationship between these be-
liefs and initial participation. The results of the present
study may indicate that the behaviour of refusing a sin-
gle screening offer is different from the behaviour of re-
fusing multiple screening offers. Consistent refusal
might instead reflect an informed decision (the decision
to refuse screening is based on adequate knowledge of
the screening test, its purpose and limitations [40]) to
not participate in FOB-based CRC screening. Further re-
search is required to establish whether lower response
efficacy for FOBT in this study was a result of inad-
equate knowledge of FOBT or reflects a preference for
alternate forms of screening such as colonoscopy.
Whilst this study identified several social cognitive
predictors of patterns of adherence, the risk ratios asso-
ciated with these predictors were smaller than those ofsimilar studies in the initial screening literature [25,41].
There are several possible explanations for this finding.
Firstly, this study utilised a prospective design where
beliefs about FOBT screening were obtained before the
study outcomes (participation in three rounds of screen-
ing) were measured. Results presented here therefore
cannot account for possible changes in these beliefs that
may have occurred over the three year screening period
[42]. Secondly, whilst the study utilised existing social
cognitive scales where possible, some variables (for ex-
ample, severity) were measured using only two items,
whilst satisfaction was measured with only one item. It
may be necessary to include more extensive measures in
the future in order to increase the reliability of the re-
sults, particularly in relation to satisfaction. Results may
also indicate that additional psychosocial variables are
required to explain adherence behaviour. Future re-
search should consider exploring the use of other behav-
ioural variables, for example those associated with
behaviour maintenance (for example, planning processes
and maintenance self-efficacy [43]), to better explain var-
iations in rescreening adherence.
Finally, the small sample sizes of some adherence cat-
egories (for example the drop out and intermittent reparti-
cipation categories), particularly in the secondary analyses,
should also be taken into consideration. Ideally, for multi-
variate analyses, the number of parameters included in each
model should be n/10- 1 where n is the sample size of the
smallest comparison group [44]. Whilst these requirements
were met in the primary analyses, the group sizes were too
small to meet these requirements amongst the satisfaction
subgroup analyses. It is possible therefore that the contribu-
tion of the social cognitive variables were small or non-
existent as a result of the small sample size rather than a
lack of association. Repeating the analyses with a larger
sample, or collapsing some of the adherence categories,
may be required to establish the contribution of social cog-
nitive variables to adherence behaviour particularly when
satisfaction with prior screening is taken into consideration.
This study is amongst the first to document patterns
of ongoing adherence to FOBT screening [9,11]. In this
study, outcomes were based on both observed (per
protocol) and observed plus self-reported (per and ex
protocol) adherence to annual FOB-based screening.
The inclusion of self-report data ensured that partici-
pants were not misclassified as being non-adherent
when screening had occurred independent of the study
[45]. This is particularly important in the current Aus-
tralian context where a national bowel cancer screening
program offers free screening to select age groups within
the target population [3,5] and people can also access
tests from doctors and pharmacies. Self-report data how-
ever is limited by inaccurate recall [46] and the potential
for participants to exaggerate compliance to conform
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http://www.biomedcentral.com/1471-2458/14/238with study or personal expectations [47]. Whilst efforts
were made to simplify self-report by restricting recall to
a single recent screening experience [48,49], results
should be interpreted in light of these potential limita-
tions. In addition, this study measured adherence to an
annual program of FIT screening. Australian screening
recommendations allow for either an annual or beiannial
screening interval [2] and it is therefore possible that
some participants participated irregularly as a result of
these recommendations.
This study is the first to identify differences in behav-
ioural and demographic characteristics of non-adherence
beyond two screening rounds. Whilst observed differences
between the adherence categories for demographic, back-
ground and social cognitive variables support the use of a
descriptive framework for understanding rescreening ad-
herence there are limitations to this approach.
Screening participation is an ongoing behaviour; the
analyses presented here describe participants based on
observed behaviour only over three consecutive screen-
ing rounds, and labels assigned to participants’ behav-
iours will change from one round to the next; category
membership is not fixed. The findings presented here
suggest characteristics that may be targeted at a broad
population level to improve rates of participation; but
they may not be useful for determining how an individ-
ual may behave in the future.
In addition, predefined behavioural definitions were
used to guide the categorisation of invitees and some
definitions collapsed multiple patterns of behaviour. This
approach was beneficial as it allowed for a detailed com-
parison of several different types of adherence behaviour
without focusing on all eight of the observed patterns.
This is particularly relevant for studies focusing on
greater numbers of screening rounds, where possible
patterns of behaviour will continue to increase. This ap-
proach does however overlook the potential for differ-
ences within the categories, for example, potential
differences between sustained and sporadic participation
[9]. Future research may want to consider exploring al-
ternate rules for categorisation in order to determine the
most effective approach for describing, and improving,
rescreening adherence.Conclusions
This study identified several demographic, background and
behavioural variables predictive of non-adherence to three
annual offers of FIT screening for CRC. Different combina-
tions of demographic and behavioural variables predicted
different patterns of rescreening adherence. Less satisfac-
tory experiences with screening before study involvement
was a major determinant of non-adherence to the screening
offered in the study.Endnote
a‘Ancillary only’ is a private health insurance policy
available in Australia that provides benefits for ancillary
treatments (e.g., dental, physiotherapy) but does not pro-
vide benefits for hospital visits.
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